Great partners, well oversold, FDA approved, small float, lots o

10 พ.ย. 2014

This is worth owning at $1.33. Great partners in Roche and Genentech, lots of cash (55M), small float, and small debt. Bleed rate is also very small. Great potential here with this falling wedge pattern...